Quantcast

Latest Histone deacetylase Stories

2012-03-01 11:02:05

Neuroscientists show that HDAC2 enzyme could be a good target for new drugs MIT neuroscientists have shown that an enzyme overproduced in the brains of Alzheimer's patients creates a blockade that shuts off genes necessary to form new memories. Furthermore, by inhibiting that enzyme in mice, the researchers were able to reverse Alzheimer's symptoms. The finding suggests that drugs targeting the enzyme, known as HDAC2, could be a promising new approach to treating the disease, which...

2012-03-01 01:56:53

In a mouse model of Alzheimer's disease, memory problems stem from an overactive enzyme that shuts off genes related to neuron communication, a new study says. When researchers genetically blocked the enzyme, called HDAC2, they 'reawakened' some of the neurons and restored the animals' cognitive function. The results suggest that drugs that inhibit this particular enzyme would make good treatments for some of the most devastating effects of the incurable neurodegenerative disease. "It's...

2012-03-01 01:55:51

NIH-funded research could lead to new therapy A repression of gene activity in the brain appears to be an early event affecting people with Alzheimer's disease, researchers funded by the National Institutes of Health have found. In mouse models of Alzheimer's disease, this epigenetic blockade and its effects on memory were treatable. "These findings provide a glimpse of the brain shutting down the ability to form new memories gene by gene in Alzheimer's disease, and offer hope that we...

2012-02-22 10:24:05

Researchers at National University of Ireland Galway have made a significant scientific discovery in the fight against Huntington's disease. Huntington's disease is an incurable, inherited, neurodegenerative disorder that causes uncontrolled movements, emotional disturbances, and severe mental deterioration. It affects over 100,000 people worldwide, with another 300,000 likely to develop symptoms in their lifetime. There is currently no way to halt progression of the disease, and available...

2012-01-10 23:35:12

University of Leicester scientists announce a major advance in understanding the regulation of an important cancer target in Nature paper Scientists at the University of Leicester have opened up a whole new approach to the therapeutic intervention for a family of anti-cancer drug targets, thanks to a completely new and unexpected finding. Professor Schwabe and his colleagues, Drs Watson, Fairall and Santos, have published their research this week in leading science magazine Nature...

2011-12-28 08:12:12

The findings could point the way to new therapies Scientists at The Scripps Research Institute have discovered that DNA stays too tightly wound in certain brain cells of schizophrenic subjects. The findings suggest that drugs already in development for other diseases might eventually offer hope as a treatment for schizophrenia and related conditions in the elderly. The research, now available online in the new Nature journal, Translational Psychiatry, shows the deficit is especially...

2011-12-13 13:05:25

National Phase III clinical trial will test histone deacetylase inhibitor with frontline therapy Adding a drug that activates genes to frontline combination therapy for acute myeloid leukemia resulted in an 85 percent remission rate after initial treatment, researchers at The University of Texas MD Anderson Cancer Center reported at the 53rd Annual Meeting of the American Society of Hematology. Results of the Phase II clinical trial of 75 patients set the stage for a national Phase III...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related